The latest closing stock price for MaxCyte as of July 02, 2025 is 2.24.
An investor who bought $1,000 worth of MaxCyte stock at the IPO in 2021 would have $-868 today, roughly -1 times their original investment - a -39.75% compound annual growth rate over 4 years.
The all-time high MaxCyte stock closing price was 17.20 on September 03, 2021.
The MaxCyte 52-week high stock price is 5.20, which is 132.1% above the current share price.
The MaxCyte 52-week low stock price is 2.00, which is 10.7% below the current share price.
The average MaxCyte stock price for the last 52 weeks is 3.58.
An investor who bought $1,000 worth of MaxCyte stock at the IPO in 2021 would have $-868 today, roughly -1 times their original investment - a -39.75% compound annual growth rate over 4 years.
The all-time high MaxCyte stock closing price was 17.20 on September 03, 2021.
The MaxCyte 52-week high stock price is 5.20, which is 132.1% above the current share price.
The MaxCyte 52-week low stock price is 2.00, which is 10.7% below the current share price.
The average MaxCyte stock price for the last 52 weeks is 3.58.